A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes.


Journal

Nature cell biology
ISSN: 1476-4679
Titre abrégé: Nat Cell Biol
Pays: England
ID NLM: 100890575

Informations de publication

Date de publication:
04 2023
Historique:
received: 11 05 2022
accepted: 02 02 2023
medline: 18 4 2023
pubmed: 18 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

The pancreatic islets are composed of discrete hormone-producing cells that orchestrate systemic glucose homeostasis. Here we identify subsets of beta cells using a single-cell transcriptomic approach. One subset of beta cells marked by high CD63 expression is enriched for the expression of mitochondrial metabolism genes and exhibits higher mitochondrial respiration compared with CD63

Identifiants

pubmed: 36928765
doi: 10.1038/s41556-023-01103-1
pii: 10.1038/s41556-023-01103-1
pmc: PMC10449536
mid: NIHMS1921036
doi:

Substances chimiques

Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

565-578

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK121140
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK098085
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK048873
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK121844
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK063608
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK056626
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK112217
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Festa, A., Williams, K., D’Agostino, R. Jr., Wagenknecht, L. E. & Haffner, S. M. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55, 1114–1120 (2006).
doi: 10.2337/diabetes.55.04.06.db05-1100 pubmed: 16567536
Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6, 361–369 (2018).
doi: 10.1016/S2213-8587(18)30051-2 pubmed: 29503172
Gomez-Banoy, N. et al. Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. Nat. Med. 25, 1739–1747 (2019).
doi: 10.1038/s41591-019-0610-4 pubmed: 31700183 pmcid: 7256970
Tabak, A. G. et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373, 2215–2221 (2009).
doi: 10.1016/S0140-6736(09)60619-X pubmed: 19515410 pmcid: 2726723
Wagner, R. et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat. Med. 27, 49–57 (2021).
doi: 10.1038/s41591-020-1116-9 pubmed: 33398163
Haythorne, E. et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic beta-cells. Nat. Commun. 10, 2474 (2019).
doi: 10.1038/s41467-019-10189-x pubmed: 31171772 pmcid: 6554411
Sharma, R. B., Landa-Galvan, H. V. & Alonso, L. C. Living dangerously: protective and harmful ER stress responses in pancreatic beta-cells. Diabetes 70, 2431–2443 (2021).
doi: 10.2337/dbi20-0033 pubmed: 34711668 pmcid: 8564401
Accili, D. et al. When beta-cells fail: lessons from dedifferentiation. Diabetes Obes. Metab. 18, 117–122 (2016).
doi: 10.1111/dom.12723 pubmed: 27615140 pmcid: 5021187
Hunter, C. S. & Stein, R. W. Evidence for loss in identity, de-differentiation, and trans-differentiation of islet beta-cells in type 2 diabetes. Front. Genet. 8, 35 (2017).
doi: 10.3389/fgene.2017.00035 pubmed: 28424732 pmcid: 5372778
Knudsen, J. G. & Rorsman, P. Beta cell dysfunction in type 2 diabetes: drained of energy? Cell Metab. 29, 1–2 (2019).
doi: 10.1016/j.cmet.2018.12.015 pubmed: 30625305
Gutierrez, G. D., Gromada, J. & Sussel, L. Heterogeneity of the pancreatic beta cell. Front. Genet. 8, 22 (2017).
doi: 10.3389/fgene.2017.00022 pubmed: 28321233 pmcid: 5337801
Pipeleers, D. G. Heterogeneity in pancreatic beta-cell population. Diabetes 41, 777–781 (1992).
doi: 10.2337/diab.41.7.777 pubmed: 1612191
Muller, A. et al. 3D FIB-SEM reconstruction of microtubule-organelle interaction in whole primary mouse beta cells. J. Cell Biol. 220, e202010039 (2021).
doi: 10.1083/jcb.202010039 pubmed: 33326005
Katsuta, H. et al. Subpopulations of GFP-marked mouse pancreatic beta-cells differ in size, granularity, and insulin secretion. Endocrinology 153, 5180–5187 (2012).
doi: 10.1210/en.2012-1257 pubmed: 22919061 pmcid: 3473214
Salomon, D. & Meda, P. Heterogeneity and contact-dependent regulation of hormone secretion by individual B cells. Exp. Cell. Res. 162, 507–520 (1986).
doi: 10.1016/0014-4827(86)90354-X pubmed: 3510882
Schuit, F. C., In’t Veld, P. A. & Pipeleers, D. G. Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc. Natl Acad. Sci. USA 85, 3865–3869 (1988).
doi: 10.1073/pnas.85.11.3865 pubmed: 3287379 pmcid: 280320
Jetton, T. L. & Magnuson, M. A. Heterogeneous expression of glucokinase among pancreatic beta cells. Proc. Natl Acad. Sci. USA 89, 2619–2623 (1992).
doi: 10.1073/pnas.89.7.2619 pubmed: 1557365 pmcid: 48713
Kiekens, R. et al. Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J. Clin. Invest. 89, 117–125 (1992).
doi: 10.1172/JCI115551 pubmed: 1729264 pmcid: 442826
Giordano, E., Bosco, D., Cirulli, V. & Meda, P. Repeated glucose stimulation reveals distinct and lasting secretion patterns of individual rat pancreatic B cells. J. Clin. Invest. 87, 2178–2185 (1991).
doi: 10.1172/JCI115251 pubmed: 2040700 pmcid: 296977
Van Schravendijk, C. F., Kiekens, R. & Pipeleers, D. G. Pancreatic beta cell heterogeneity in glucose-induced insulin secretion. J. Biol. Chem. 267, 21344–21348 (1992).
doi: 10.1016/S0021-9258(19)36615-3 pubmed: 1400446
Heimberg, H. et al. Heterogeneity in glucose sensitivity among pancreatic beta-cells is correlated to differences in glucose phosphorylation rather than glucose transport. EMBO J. 12, 2873–2879 (1993).
doi: 10.1002/j.1460-2075.1993.tb05949.x pubmed: 8335003 pmcid: 413540
Soria, B., Chanson, M., Giordano, E., Bosco, D. & Meda, P. Ion channels of glucose-responsive and -unresponsive beta-cells. Diabetes 40, 1069–1078 (1991).
doi: 10.2337/diab.40.8.1069 pubmed: 1713562
Holz, G. G. T., Kuhtreiber, W. M. & Habener, J. F. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361, 362–365 (1993).
doi: 10.1038/361362a0 pubmed: 8381211 pmcid: 2916679
Baron, M. et al. A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure. Cell Syst. 3, 346–360 e344 (2016).
doi: 10.1016/j.cels.2016.08.011 pubmed: 27667365 pmcid: 5228327
Muraro, M. J. et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst. 3, 385–394 e383 (2016).
doi: 10.1016/j.cels.2016.09.002 pubmed: 27693023 pmcid: 5092539
Segerstolpe, A. et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 24, 593–607 (2016).
doi: 10.1016/j.cmet.2016.08.020 pubmed: 27667667 pmcid: 5069352
Xin, Y. et al. Use of the Fluidigm C1 platform for RNA sequencing of single mouse pancreatic islet cells. Proc. Natl Acad. Sci. USA 113, 3293–3298 (2016).
doi: 10.1073/pnas.1602306113 pubmed: 26951663 pmcid: 4812709
Lawlor, N. et al. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes. Genome Res. 27, 208–222 (2017).
doi: 10.1101/gr.212720.116 pubmed: 27864352 pmcid: 5287227
Xin, Y. et al. Pseudotime ordering of single human beta-cells reveals states of insulin production and unfolded protein response. Diabetes 67, 1783–1794 (2018).
doi: 10.2337/db18-0365 pubmed: 29950394
Fang, Z. et al. Single-cell heterogeneity analysis and CRISPR screen identify key beta-cell-specific disease genes. Cell Rep. 26, 3132–3144 e3137 (2019).
doi: 10.1016/j.celrep.2019.02.043 pubmed: 30865899 pmcid: 6573026
Xin, Y. et al. Single-cell RNAseq reveals that pancreatic beta-cells from very old male mice have a young gene signature. Endocrinology 157, 3431–3438 (2016).
doi: 10.1210/en.2016-1235 pubmed: 27466694
Dominguez-Gutierrez, G., Xin, Y. & Gromada, J. Heterogeneity of human pancreatic beta-cells. Mol. Metab. 27S, S7–S14 (2019).
doi: 10.1016/j.molmet.2019.06.015 pubmed: 31500834
Mawla, A. M. & Huising, M. O. Navigating the depths and avoiding the shallows of pancreatic islet cell transcriptomes. Diabetes 68, 1380–1393 (2019).
doi: 10.2337/dbi18-0019 pubmed: 31221802 pmcid: 6609986
Camunas-Soler, J. et al. Patch-seq links single-cell transcriptomes to human islet dysfunction in diabetes. Cell Metab. 31, 1017–1031 e1014 (2020).
doi: 10.1016/j.cmet.2020.04.005 pubmed: 32302527 pmcid: 7398125
Bar, Y. & Efrat, S. The NOTCH pathway in beta-cell growth and differentiation. Vitam. Horm. 95, 391–405 (2014).
doi: 10.1016/B978-0-12-800174-5.00015-6 pubmed: 24559926
Bartolome, A., Zhu, C., Sussel, L. & Pajvani, U. B. Notch signaling dynamically regulates adult beta cell proliferation and maturity. J. Clin. Invest. 129, 268–280 (2019).
doi: 10.1172/JCI98098 pubmed: 30375986
Kelly, P. et al. Rap1 promotes multiple pancreatic islet cell functions and signals through mammalian target of rapamycin complex 1 to enhance proliferation. J. Biol. Chem. 285, 15777–15785 (2010).
doi: 10.1074/jbc.M109.069112 pubmed: 20339002 pmcid: 2871445
Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523–530 (2014).
doi: 10.1093/bioinformatics/btt703 pubmed: 24336805
Kang, H. S. et al. Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression. Mol. Cell. Biol. 29, 6366–6379 (2009).
doi: 10.1128/MCB.01259-09 pubmed: 19805515 pmcid: 2786880
Osipovich, A. B. et al. Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3. Development 141, 2939–2949 (2014).
doi: 10.1242/dev.104810 pubmed: 25053427 pmcid: 4197673
Newsholme, P., Keane, K. N., Carlessi, R. & Cruzat, V. Oxidative stress pathways in pancreatic beta-cells and insulin-sensitive cells and tissues: importance to cell metabolism, function, and dysfunction. Am. J. Physiol. Cell Physiol. 317, C420–C433 (2019).
doi: 10.1152/ajpcell.00141.2019 pubmed: 31216193
Lee, J. H. et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 58, 344–351 (2009).
doi: 10.2337/db07-1795 pubmed: 19008341 pmcid: 2628607
Singh, C. K. et al. The role of sirtuins in antioxidant and redox signaling. Antioxid. Redox Signal 28, 643–661 (2018).
doi: 10.1089/ars.2017.7290 pubmed: 28891317 pmcid: 5824489
Baumel-Alterzon, S., Katz, L. S., Brill, G., Garcia-Ocana, A. & Scott, D. K. Nrf2: the master and captain of beta cell fate. Trends Endocrinol. Metab. 32, 7–19 (2021).
doi: 10.1016/j.tem.2020.11.002 pubmed: 33243626
Gupta, R. K. et al. The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J. Clin. Invest. 115, 1006–1015 (2005).
doi: 10.1172/JCI200522365 pubmed: 15761495 pmcid: 1059446
Miura, A. et al. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. J. Biol. Chem. 281, 5246–5257 (2006).
doi: 10.1074/jbc.M507496200 pubmed: 16377800
Flannick, J., Johansson, S. & Njolstad, P. R. Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes. Nat. Rev. Endocrinol. 12, 394–406 (2016).
doi: 10.1038/nrendo.2016.50 pubmed: 27080136
Lee, A. H., Heidtman, K., Hotamisligil, G. S. & Glimcher, L. H. Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion. Proc. Natl Acad. Sci. USA 108, 8885–8890 (2011).
doi: 10.1073/pnas.1105564108 pubmed: 21555585 pmcid: 3102350
Juliana, C. A. et al. A PDX1-ATF transcriptional complex governs beta cell survival during stress. Mol. Metab. 17, 39–48 (2018).
doi: 10.1016/j.molmet.2018.07.007 pubmed: 30174228 pmcid: 6197747
Salinno, C. et al. CD81 marks immature and dedifferentiated pancreatic beta-cells. Mol. Metab. 49, 101188 (2021).
doi: 10.1016/j.molmet.2021.101188 pubmed: 33582383 pmcid: 7932895
Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).
doi: 10.1002/cpz1.90 pubmed: 33780170 pmcid: 8152575
Sachs, S. et al. Targeted pharmacological therapy restores beta-cell function for diabetes remission. Nat. Metab. 2, 192–209 (2020).
doi: 10.1038/s42255-020-0171-3 pubmed: 32694693
van der Meulen, T. et al. Virgin beta cells persist throughout life at a neogenic niche within pancreatic islets. Cell Metab. 25, 911–926 e916 (2017).
doi: 10.1016/j.cmet.2017.03.017 pubmed: 28380380 pmcid: 8586897
Qiu, W. L. et al. Deciphering pancreatic islet beta cell and alpha cell maturation pathways and characteristic features at the single-cell level. Cell Metab. 25, 1194–1205 e1194 (2017).
doi: 10.1016/j.cmet.2017.04.003 pubmed: 28467935
Farack, L. et al. Transcriptional heterogeneity of beta cells in the intact pancreas. Dev. Cell 48, 115–125 e114 (2019).
doi: 10.1016/j.devcel.2018.11.001 pubmed: 30503750
Dusaulcy, R. et al. High-fat diet impacts more changes in beta-cell compared to alpha-cell transcriptome. PLoS ONE 14, e0213299 (2019).
doi: 10.1371/journal.pone.0213299 pubmed: 30849121 pmcid: 6407777
Backe, M. B., Moen, I. W., Ellervik, C., Hansen, J. B. & Mandrup-Poulsen, T. Iron regulation of pancreatic beta-cell functions and oxidative stress. Annu Rev. Nutr. 36, 241–273 (2016).
doi: 10.1146/annurev-nutr-071715-050939 pubmed: 27146016
Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150, 1223–1234 (2012).
doi: 10.1016/j.cell.2012.07.029 pubmed: 22980982 pmcid: 3445031
Kim-Muller, J. Y. et al. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metab. 20, 593–602 (2014).
doi: 10.1016/j.cmet.2014.08.012 pubmed: 25264246 pmcid: 4192072
Kim-Muller, J. Y. et al. Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic beta cells in diabetic mice. Nat. Commun. 7, 12631 (2016).
doi: 10.1038/ncomms12631 pubmed: 27572106 pmcid: 5013715
Pasquier, A. et al. Lysosomal degradation of newly formed insulin granules contributes to beta cell failure in diabetes. Nat. Commun. 10, 3312 (2019).
doi: 10.1038/s41467-019-11170-4 pubmed: 31346174 pmcid: 6658524
Dorrell, C. et al. Human islets contain four distinct subtypes of beta cells. Nat. Commun. 7, 11756 (2016).
doi: 10.1038/ncomms11756 pubmed: 27399229 pmcid: 4942571
Ellenbroek, J. H. et al. Topologically heterogeneous beta cell adaptation in response to high-fat diet in mice. PLoS ONE 8, e56922 (2013).
doi: 10.1371/journal.pone.0056922 pubmed: 23441226 pmcid: 3575501
Tersey, S. A. et al. Episodic beta-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice. FASEB J. https://doi.org/10.1096/fj.201800150rr (2018).
Benninger, R. K. P. & Kravets, V. The physiological role of β-cell heterogeneity in pancreatic islet function. Nat. Rev. Endocrinol. 18, 9–22 (2022).
doi: 10.1038/s41574-021-00568-0 pubmed: 34667280
Bader, E. et al. Identification of proliferative and mature beta-cells in the islets of Langerhans. Nature 535, 430–434 (2016).
doi: 10.1038/nature18624 pubmed: 27398620
Karaca, M. et al. Exploring functional beta-cell heterogeneity in vivo using PSA-NCAM as a specific marker. PLoS ONE 4, e5555 (2009).
doi: 10.1371/journal.pone.0005555 pubmed: 19440374 pmcid: 2679208
Wang, Y. J. et al. Single-cell transcriptomics of the human endocrine pancreas. Diabetes 65, 3028–3038 (2016).
doi: 10.2337/db16-0405 pubmed: 27364731 pmcid: 5033269
Li, J. et al. Single-cell transcriptomes reveal characteristic features of human pancreatic islet cell types. EMBO Rep. 17, 178–187 (2016).
doi: 10.15252/embr.201540946 pubmed: 26691212
Wang, Y. J. & Kaestner, K. H. Single-cell RNA-seq of the pancreatic islets—a promise not yet fulfilled? Cell Metab. 29, 539–544 (2019).
doi: 10.1016/j.cmet.2018.11.016 pubmed: 30581120
Huotari, M. A. et al. ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture. Endocrinology 143, 4437–4446 (2002).
doi: 10.1210/en.2002-220382 pubmed: 12399441
Doyle, M. E. & Egan, J. M. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol. Ther. 113, 546–593 (2007).
doi: 10.1016/j.pharmthera.2006.11.007 pubmed: 17306374
Lun, A. T., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Res 5, 2122 (2016).
pubmed: 27909575 pmcid: 5112579
Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137–145 (2020).
doi: 10.1038/s41592-019-0654-x pubmed: 31792435
Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
doi: 10.1186/s13059-019-1874-1 pubmed: 31870423 pmcid: 6927181
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 e1821 (2019).
doi: 10.1016/j.cell.2019.05.031 pubmed: 31178118 pmcid: 6687398
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38–44 (2019).
doi: 10.1038/nbt.4314
Waltman, L. & van Eck, N. J. A smart local moving algorithm for large-scale modularity-based community detection. Eur. Phys. J. B 86, 471 (2013).
doi: 10.1140/epjb/e2013-40829-0
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
doi: 10.1093/bioinformatics/bts635 pubmed: 23104886
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
doi: 10.1093/bioinformatics/btt656 pubmed: 24227677
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
doi: 10.1186/s13059-014-0550-8 pubmed: 25516281 pmcid: 4302049
Smelt, M. J., Faas, M. M., de Haan, B. J. & de Vos, P. Pancreatic beta-cell purification by altering FAD and NAD(P)H metabolism. Exp. Diabetes Res 2008, 165360 (2008).
doi: 10.1155/2008/165360 pubmed: 18670618 pmcid: 2491326

Auteurs

Alfonso Rubio-Navarro (A)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Excellence Research Unit "Modeling Nature" (MNat), CTS-963-Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), University Hospitals of Granada-University of Granada, Granada, Spain.

Nicolás Gómez-Banoy (N)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Lisa Stoll (L)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Friederike Dündar (F)

Department of Physiology and Biophysics, Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.

Alex M Mawla (AM)

Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis, CA, USA.

Lunkun Ma (L)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Eric Cortada (E)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Paul Zumbo (P)

Department of Physiology and Biophysics, Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.

Ang Li (A)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Moritz Reiterer (M)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Nathalia Montoya-Oviedo (N)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Lipids and Diabetes Laboratory, Department of Physiological Sciences, Faculty of Medicine, National University of Colombia, Bogotá, Colombia.

Edwin A Homan (EA)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Norihiro Imai (N)

Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan.

Ankit Gilani (A)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Chengyang Liu (C)

Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Ali Naji (A)

Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Boris Yang (B)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Angie Chi Nok Chong (ACN)

Department of Surgery, Weill Cornell Medicine, New York, NY, USA.

David E Cohen (DE)

Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Shuibing Chen (S)

Department of Surgery, Weill Cornell Medicine, New York, NY, USA.

Jingli Cao (J)

Cardiovascular Research Institute, Weill Cornell Medicine, New York, NY, USA.

Geoffrey S Pitt (GS)

Cardiovascular Research Institute, Weill Cornell Medicine, New York, NY, USA.

Mark O Huising (MO)

Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis, CA, USA.
Department of Physiology and Membrane Biology, School of Medicine, University of California Davis, Davis, CA, USA.

Doron Betel (D)

Department of Physiology and Biophysics, Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
Institute for Computational Biomedicine, Division of Hematology and Medical Oncology, Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.

James C Lo (JC)

Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. jlo@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH